作者回复:慢性静脉疾病、血小板和止血功能异常与色素紫癜性皮肤病的发病机制有关。

IF 1.6 4区 医学 Q3 PERIPHERAL VASCULAR DISEASE Phlebology Pub Date : 2023-04-01 DOI:10.1177/02683555231153019
Parsi K, Connor DE
{"title":"作者回复:慢性静脉疾病、血小板和止血功能异常与色素紫癜性皮肤病的发病机制有关。","authors":"Parsi K, Connor DE","doi":"10.1177/02683555231153019","DOIUrl":null,"url":null,"abstract":"Dear Editor, We thank you for drawing our attention the letter of Yetkin et al. entitled Pigmented Purpuric Dermatosis-Ecchymosis and Chronic Venous Disease in response to our paper Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatoses. The authors of the letter have erroneously interpreted ecchymosis and purpura to be synonymous with pigmented purpuric dermatosis (PPD, also known as capillaritis). While ecchymosis is the clinical manifestation of an anatomical bleed, PPD is a distinct dermatological condition with a complex aetiology that is vastly distinct from a simple purpura or ecchymosis. The diagnosis of PPD is confirmed by a biopsy of the affected lesion where histology would typically reveal a perivascular lymphocytic infiltrate and a dermal red cell extravasation. In some sub-categories of PPD, a lichenoid infiltrate, dermal spongiosis or a granulomatous component may be present. PPD is a differential diagnosis for variants of cutaneous T-cell lymphoma (CTCL) and in particular the angiocentric mycosis fungoides (CTCL) that may clinically resemble PPD. It has also been suggested that PPD may be a precursor of CTCL. Various other conditions and in particular cutaneous sarcoidosis may resemble PPD. Hence, a PPD eruption should not be dismissed as simple purpura or pigmentation and appropriate dermatological assessment including a biopsy should be carried out. The novel finding of our study is that patients with PPD would benefit from further assessment of congenital or acquired haemostatic abnormalities that result in thrombocytopenia or affect platelet function. In particular we demonstrated that drugs or supplements such as fish oil may inhibit platelet function contributing to the pathogenesis of PPD. We recommended cessation of any modifiable risk factor when clinically appropriate and treatment of an underlying chronic venous disease when present. Many dermatological conditions may appear clinically similar to non-dermatologists and the confusion is exacerbated when different conditions are titled containing a similar lexicon. Not all conditions containing the term purpura indicate simple bruising as evident from the range of conditions containing the term purpura including PPD, Henoch-Schonlein purpura (IgA vasculitis), thrombotic thrombocytopenic purpura (TTP) and immune-mediated thrombocytopenia (immune thrombocytopenic purpura; ITP). A referral to a dermatologist and appropriate histological confirmation of the clinical diagnosis is recommended when practitioners are dealing with unusual pigmented or purpuric conditions.","PeriodicalId":20139,"journal":{"name":"Phlebology","volume":"38 3","pages":"196-197"},"PeriodicalIF":1.6000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Authors Reply: Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatoses.\",\"authors\":\"Parsi K, Connor DE\",\"doi\":\"10.1177/02683555231153019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Dear Editor, We thank you for drawing our attention the letter of Yetkin et al. entitled Pigmented Purpuric Dermatosis-Ecchymosis and Chronic Venous Disease in response to our paper Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatoses. The authors of the letter have erroneously interpreted ecchymosis and purpura to be synonymous with pigmented purpuric dermatosis (PPD, also known as capillaritis). While ecchymosis is the clinical manifestation of an anatomical bleed, PPD is a distinct dermatological condition with a complex aetiology that is vastly distinct from a simple purpura or ecchymosis. The diagnosis of PPD is confirmed by a biopsy of the affected lesion where histology would typically reveal a perivascular lymphocytic infiltrate and a dermal red cell extravasation. In some sub-categories of PPD, a lichenoid infiltrate, dermal spongiosis or a granulomatous component may be present. PPD is a differential diagnosis for variants of cutaneous T-cell lymphoma (CTCL) and in particular the angiocentric mycosis fungoides (CTCL) that may clinically resemble PPD. It has also been suggested that PPD may be a precursor of CTCL. Various other conditions and in particular cutaneous sarcoidosis may resemble PPD. Hence, a PPD eruption should not be dismissed as simple purpura or pigmentation and appropriate dermatological assessment including a biopsy should be carried out. The novel finding of our study is that patients with PPD would benefit from further assessment of congenital or acquired haemostatic abnormalities that result in thrombocytopenia or affect platelet function. In particular we demonstrated that drugs or supplements such as fish oil may inhibit platelet function contributing to the pathogenesis of PPD. We recommended cessation of any modifiable risk factor when clinically appropriate and treatment of an underlying chronic venous disease when present. Many dermatological conditions may appear clinically similar to non-dermatologists and the confusion is exacerbated when different conditions are titled containing a similar lexicon. Not all conditions containing the term purpura indicate simple bruising as evident from the range of conditions containing the term purpura including PPD, Henoch-Schonlein purpura (IgA vasculitis), thrombotic thrombocytopenic purpura (TTP) and immune-mediated thrombocytopenia (immune thrombocytopenic purpura; ITP). A referral to a dermatologist and appropriate histological confirmation of the clinical diagnosis is recommended when practitioners are dealing with unusual pigmented or purpuric conditions.\",\"PeriodicalId\":20139,\"journal\":{\"name\":\"Phlebology\",\"volume\":\"38 3\",\"pages\":\"196-197\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2023-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Phlebology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/02683555231153019\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phlebology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/02683555231153019","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Authors Reply: Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatoses.
Dear Editor, We thank you for drawing our attention the letter of Yetkin et al. entitled Pigmented Purpuric Dermatosis-Ecchymosis and Chronic Venous Disease in response to our paper Chronic venous disease, platelet and haemostatic abnormalities contribute to the pathogenesis of pigmented purpuric dermatoses. The authors of the letter have erroneously interpreted ecchymosis and purpura to be synonymous with pigmented purpuric dermatosis (PPD, also known as capillaritis). While ecchymosis is the clinical manifestation of an anatomical bleed, PPD is a distinct dermatological condition with a complex aetiology that is vastly distinct from a simple purpura or ecchymosis. The diagnosis of PPD is confirmed by a biopsy of the affected lesion where histology would typically reveal a perivascular lymphocytic infiltrate and a dermal red cell extravasation. In some sub-categories of PPD, a lichenoid infiltrate, dermal spongiosis or a granulomatous component may be present. PPD is a differential diagnosis for variants of cutaneous T-cell lymphoma (CTCL) and in particular the angiocentric mycosis fungoides (CTCL) that may clinically resemble PPD. It has also been suggested that PPD may be a precursor of CTCL. Various other conditions and in particular cutaneous sarcoidosis may resemble PPD. Hence, a PPD eruption should not be dismissed as simple purpura or pigmentation and appropriate dermatological assessment including a biopsy should be carried out. The novel finding of our study is that patients with PPD would benefit from further assessment of congenital or acquired haemostatic abnormalities that result in thrombocytopenia or affect platelet function. In particular we demonstrated that drugs or supplements such as fish oil may inhibit platelet function contributing to the pathogenesis of PPD. We recommended cessation of any modifiable risk factor when clinically appropriate and treatment of an underlying chronic venous disease when present. Many dermatological conditions may appear clinically similar to non-dermatologists and the confusion is exacerbated when different conditions are titled containing a similar lexicon. Not all conditions containing the term purpura indicate simple bruising as evident from the range of conditions containing the term purpura including PPD, Henoch-Schonlein purpura (IgA vasculitis), thrombotic thrombocytopenic purpura (TTP) and immune-mediated thrombocytopenia (immune thrombocytopenic purpura; ITP). A referral to a dermatologist and appropriate histological confirmation of the clinical diagnosis is recommended when practitioners are dealing with unusual pigmented or purpuric conditions.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Phlebology
Phlebology 医学-外周血管病
CiteScore
3.30
自引率
11.80%
发文量
84
审稿时长
6-12 weeks
期刊介绍: The leading scientific journal devoted entirely to venous disease, Phlebology is the official journal of several international societies devoted to the subject. It publishes the results of high quality studies and reviews on any factor that may influence the outcome of patients with venous disease. This journal provides authoritative information about all aspects of diseases of the veins including up to the minute reviews, original articles, and short reports on the latest treatment procedures and patient outcomes to help medical practitioners, allied health professionals and scientists stay up-to-date on developments. Print ISSN: 0268-3555
期刊最新文献
Implementation of a varicose vein module added to Swedvasc, the Swedish National Registry for vascular surgery. Long-term results and predictors of failure after mechanochemical endovenous ablation in the treatment of primary great saphenous vein incompetence. Durability and efficacy of the ELVeS® Radial® 2ring slim fiber for multiple ablations. Punch grafting for the treatment of ulcerated atrophie blanche. Pigmentation of lower limbs: Contribution of haemosiderin and melanin in chronic venous insufficiency and related disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1